Astera Labs: The Long View
What the filings say about its story, dilution and cash runway.
Disclosure: one or more of our editors own shares of Astera Labs (ALAB) as a long-term investment. This page is information, not investment advice.
1. In one paragraph
Last updated Nov 4, 2026. Reflects the 10-K for 2025 and the 10-Q for Q3 2026.
Astera Labs sells chips, boards and modules that move data inside AI data-centre servers, and in 2025 its revenue was $852.5M (+115%), all from product sales (no engineering-service revenue was recorded in 2025).
- Business: founded in October 2017 (prospectus), it designs chips, boards and modules that move data between AI accelerators, CPUs, memory and network cards inside data-centre servers and racks.
- Manufacturing: it is fabless; a single manufacturing partner makes its integrated circuits (10-K 2025).
- Products: four families, all run by its COSMOS software: Aries retimers (signal boosters for PCIe, the standard high-speed link inside servers), Taurus modules for Ethernet cables, Leo memory controllers (for CXL, a standard for attaching extra memory to processors) and Scorpio fabric switches (P-Series for mixed devices, X-Series for linking accelerators to each other).
- Reporting: one segment, with revenue by the billing address of its direct customers, which are mostly contract manufacturers and distributors, not the end users (10-K 2025):
| 2025 (disclosed; shares are our calculation)1 | Revenue | Share of total |
|---|---|---|
| Singapore | $277.0M | 32% |
| China | $256.3M | 30% |
| Taiwan | $247.4M | 29% |
| United States | $27.4M | 3% |
| Other | $44.4M | 5% |
| Total | $852.5M | 100% |
2. Story so far
Last updated Nov 4, 2026. Reflects the 10-K for 2025, the 10-Q for Q3 2026 and company releases through Nov 2026.
In short: Astera Labs began selling its first retimers in 2020 and grew on demand from AI servers. It listed on Nasdaq in March 2024 and turned profitable under US accounting rules from late 2024. In 2026 Amazon signed a second, larger purchase-linked warrant and the company said its Scorpio switches would become its largest product family, while the share price rose about fivefold from its March 2026 low to its June high and then gave back about half by late October. In Q3 2026 Scorpio became its largest product family, while one direct customer reached 53% of revenue.
| Date | Milestone | Source |
|---|---|---|
| Oct 2017 | Company founded | Prospectus |
| 2020 | Commercial launch of Aries, its first product family | Prospectus |
| May 2022 | Series D preferred round at $20.339 a share: $149.9M of net cash raised, plus 0.9M common shares exchanged into the round | Prospectus, 10-K 2024 equity statement |
| Oct 14, 2022 | ★ Amazon receives a warrant for up to 1.48M shares at $20.34, vesting with Amazon’s purchases. An October 2023 amendment adds 0.83M shares on the same terms | 10-K 2025, note 10 |
| Mar 20, 2024 | ★ Shares start trading on Nasdaq after an IPO at $36.00 (the company sold 19.76M shares, including the underwriters’ option). First-day close: $62.03 (reported, Stock Analysis) | Prospectus, 10-K 2024 |
| Oct 8, 2024 | Introduces Scorpio fabric switches (P-Series and X-Series), shipping in pre-production quantities | Company release |
| Feb 10, 2025 | First quarter of positive net income under US accounting rules (GAAP): $24.7M in Q4 2024 (our calculation)2 | Q4 2024 release, 10-K 2024 |
| Nov 10, 2025 | Completes the purchase of aiXscale Photonics (fiber-to-chip optical coupling) for $31.1M | 10-K 2025 |
| Feb 5, 2026 | ★ New Amazon warrant: up to 3.26M shares at $142.82, vesting with up to $6.5B of Amazon purchases of fabric switches, signal-conditioning and optical products. Announced Feb 10 with Q4 results and the retirement of CFO Michael Tate (successor Desmond Lynch from Mar 2). Stock −21% next day, $182.86 → $143.71 (reported, Stock Analysis) | 8-K warrant, 8-K CFO |
| Feb 9, 2026 | Buys assets and a team from a private data-centre acceleration company for $74.0M ($68.4M booked as goodwill) | 10-Q Q2 2026, note 6 |
| Mar 30, 2026 | 2026 low: $97.89 intraday, $100.27 close (reported, Stock Analysis) | Stock Analysis |
| May 5, 2026 | Scorpio X-Series 320-lane switch shipping, with a production ramp expected in the second half of 2026 | Q1 2026 release |
| Jun 30, 2026 | Record close of $483.02 (intraday high $499.48) (reported, Stock Analysis) | Stock Analysis |
| Aug 4, 2026 | Q2 revenue +104%; Q3 guide of $540–560M; Scorpio to become the largest product family in Q3, “one quarter ahead of our prior expectations”. Stock −12% next day, $361.67 → $318.43 (reported, Stock Analysis) | Q2 2026 release |
| Oct 2026 | Start of our coverage: this Long View | |
| Nov 3, 2026 | ★ Q3 revenue +154%, above the guide; Q4 guide of $730–750M; Scorpio becomes the largest product family; one direct customer is 53% of revenue. Stock −4.4% next day, $233.62 → $223.27 (Nasdaq) | Q3 2026 release, 10-Q Q3 2026 |
3. Latest quarter: did the story change?
Last updated Nov 4, 2026. Reflects Q3 2026 (quarter to Sep 30, released Nov 3). Fuller write-up: Q3 2026 review.
Bottom line: Q3 revenue beat the top of guidance by 4.4% (our calculation)3 and management guided Q4 about 27% higher, with Scorpio now the largest product family. But one direct customer reached 53% of revenue, gross margin slipped again, and the 10-Q now cites inventory charges and factory overhead.
“Non-GAAP” excludes stock-based pay, acquisition costs and value changes on private equity stakes (company definition).
| Driver | Last quarter → this quarter | Management: before → now | Signal |
|---|---|---|---|
| Revenue | $392.4M (+104%) → $584.9M (+154%) | Next-quarter guide: $540–560M for Q3 (Aug 4) → $730–750M for Q4 (Nov 3) | Better |
| Scorpio fabric switches | Largest family expected in Q3 → largest family; X-Series passed P-Series | Largest in Q3, “one quarter ahead” (Aug 4) → X-Series at two customers; Scorpio over $1B annualised (Nov 3) | Better |
| GAAP gross margin | 73.3% → 72.3% | Q3 guide about 72% (Aug 4) → about 72% for Q4 (Nov 3) | Watch |
| Operating margin | Non-GAAP 39.1% → 44.7%; GAAP 22.7% → 30.6% | About 43% implied for Q3 (our calculation)4 (Aug 4) → about 45% non-GAAP for Q4 (Nov 3) | Better |
| Largest direct customer, receivables and inventory | 29% of revenue → 53%; receivables $192.5M → $284.3M; inventory $113.8M → $200.9M | No guide → no guide; the 10-Q says customer shares may move as production shifts between manufacturing partners, and inventory was built “to support anticipated demand” | Watch |
Sources: Q2 2026 release, Q3 2026 release, 10-Q Q2 2026, 10-Q Q3 2026; Nov 3 call remarks from MarketBeat’s machine transcript. “Customer A” letters can change between filings, so we compare the largest direct customer each quarter.
What changed in the filing beyond the release: gross margin’s explanation moved from “a shift in product mix” (Q2 10-Q) to “higher inventory-related charges, higher manufacturing overhead costs, as well as the impact of the Warrants” (Q3 10-Q), with no amount given. A new accounting system went live in Q3 and changed some financial controls, with no weakness reported. Legal proceedings and risk factors didn’t change in substance.
Unresolved questions: who the largest end customer is and its share of 2026 revenue; whether its current build peaks around early 2027, as an analyst suggested on the call (the CFO declined to discuss customer volumes); when the second Scorpio X customer adds revenue, which management expects in 2027; how much the inventory charges were.
4. Buybacks vs real dilution (5 years)
Last updated Nov 4, 2026. Reflects the equity statements in the 10-Ks for 2024 and 2025 and the 10-Q Q3 2026. The earliest share balance in Astera’s public filings is Dec 31, 2021, so the bridge covers four years, not five.
Dilution in one line: From Dec 31, 2021 to Dec 31, 2025 the share count (all classes: common and convertible preferred) rose 39.3%, about 8.6% a year compounded (our calculation)5. If you owned 1% of Astera Labs at the end of 2021, you’d own about 0.72% at the end of 2025 without buying more (our calculation)6. Repurchases offset about 0.7% of the new shares (0.318M of 48.329M issued; our calculation)7. More than half of the new shares (27.1M) were sold for cash in the 2022 preferred round and the 2024 IPO; the rest came mostly from employee stock awards. Our scale: High (over 3% a year).
Our rule of thumb: under 1% a year low, 1–3% moderate, over 3% high.
Change in the period Total since Dec 31, 2021
Shares outstanding at period end (all classes): 122.2M on Dec 31, 2021, 170.2M on Dec 31, 2025, +39.3% (our calculation). A bar below zero means the count fell (net buybacks).
All classes (common plus convertible preferred before the March 2024 IPO, when the preferred converted one for one; common only after), from the author's bridge (10-K equity statements); the pre-IPO preferred has no standard XBRL tag, so only the start and end counts are shown.
| Period end | Shares outstanding | Change | Buybacks (fiscal year) | Stock-based pay (fiscal year) | Stock pay as % of revenue |
|---|---|---|---|---|---|
| FY2022–FY2025 (Dec 31, 2025) | 170.2M | +39.3% | $2M (FY2022–25 total) | $436M (FY2022–25 total) | 30% (FY2022–25 total) |
| Dec 31, 2021 | 122.2M | — | — | — | — |
Shares outstanding from the balance sheets in the company's 10-K and 10-Q filings; buybacks (cash spent) and stock-based pay from its 10-Ks, via SEC EDGAR.
How we calculated this
| Share bridge, Dec 31, 2021 → Dec 31, 2025 (our calculation from disclosed equity statements; millions) | Shares |
|---|---|
| Start (common 39.6 + convertible preferred 82.6) | 122.2 |
| + Shares sold for cash: Series D preferred (2022) and IPO (2024) | +27.1 |
| + Stock options exercised | +10.8 |
| + Restricted stock units (RSUs) vested, net of 0.56M shares withheld for employee taxes in 2024 | +10.1 |
| + Employee stock purchase plan | +0.2 |
| + Shares issued for an acquisition (2025) | +0.04 |
| − Unvested shares repurchased from departing employees (2022–24; $1.5M) | −0.3 |
| End (common only; the preferred converted one for one at the IPO) | 170.2 (+39.3%) |
| 9M 2026: +4.4 from stock awards and options, +0.13 from a cashless exercise of a 2021 bank warrant, +0.05 employee purchase plan | 174.8 at Sep 30, 2026 |
- Totals use unrounded filing figures (thousands); the displayed components may not sum exactly because of rounding.
- Share basis: all classes (common plus convertible preferred before the March 2024 IPO; common only after).
- No convertible debt was outstanding at any point in the period.
- Astera effected a two-for-one reverse stock split on Feb 12, 2024 (prospectus); historical shares and per-share figures shown here are adjusted for it.
Prices paid and received:
| Period | Shares bought back | Average price paid | Spent | Shares sold for cash | Average price received | Raised | Sources |
|---|---|---|---|---|---|---|---|
| 2022 | 0.071M | $4.27 (our calculation)8 | $0.3M | 7.375M (Series D preferred) | $20.34 (company’s price: $20.339) | about $150.0M gross (our calculation)9; $149.9M net of issuance costs | 10-K 2024 equity statement; prospectus |
| 2023 | 0.207M | $0.84 (our calculation)8 | $0.2M | — | — | — | 10-K 2025 equity statement |
| 2024 | 0.040M | $26.65 (our calculation)8 | $1.1M | 19.759M (IPO, including the underwriters’ option) | $36.00 (IPO price) | $711.3M gross (our calculation)9; $672.2M after underwriting discounts | 10-K 2025 equity and cash-flow statements; prospectus |
| 2025 | — | — | — | — | — | — | 10-K 2025 equity statement |
| 2026 YTD (to Sep 30) | — | — | — | — | — | — | 10-Q Q3 2026 equity statement |
- Astera has no buyback programme. The only repurchases were unvested shares that employees had exercised early, bought back at their original cost when those employees left, so the prices are not market prices.
- Buybacks exclude the 0.56M shares ($20.1M) withheld for employee taxes when RSUs settled at the IPO.
- Sales for cash exclude option exercises and the employee purchase plan.
- For reference, the stock closed at $223.27 on Nov 4, 2026 (Nasdaq).
| Diluted shares and stock pay (disclosed; % is our calculation)10 | 2022 | 2023 | 2024 | 2025 | 9M 2026 |
|---|---|---|---|---|---|
| Weighted diluted shares (M) | 34.2 | 37.1 | 131.3 | 179.6 | 182.9 |
| Stock-based pay ($M) | 30.2 | 10.7 | 234.6 | 160.0 | 195.5 |
| Stock pay as % of revenue | 38% | 9% | 59% | 19% | 15% |
The diluted count is the one used for earnings per share; the notes explain why 2022–24 are not comparable with later years.
Notes on the diluted share count
- Loss years (2022–24) show no dilution from awards, so diluted shares equal basic.
- Before the March 2024 IPO the preferred shares were not counted, so 2022–24 are not comparable with later years.
- 2024 stock pay includes $88.9M recognised when the IPO met the vesting condition of earlier RSU grants (10-K 2024).
Amazon’s three warrants could add up to 5.58M shares as Amazon buys more; none had been exercised at Sep 30, 2026.
Shares that could still be issued (at Sep 30, 2026, [10-Q][10q326])
- Amazon’s three warrants cover up to 5.58M shares (2.32M at $20.34 from 2022–23; 3.26M at $142.82 from 2026).
- 1.87M were vested at that date, across all three, and none had been exercised.
- Unvested stock awards: 8.46M RSUs at Sep 30; $802.9M of RSU cost and $30.7M of performance-unit cost still to be expensed, over about 2.1 years.
- On Mar 20, 2026 Astera registered all 5,578,474 warrant shares for resale (S-3ASR); Astera receives no proceeds from that registration, and the 2026 warrant allows cashless exercise.
- The 2024 equity plan’s share pool rises automatically each January 1 through 2034 (10-K 2025).
Insider transactions: officers and directors sold about $786M of stock and bought none in the open market (our calculation)11.
- Net selling: about $786M, with no open-market purchases.
- Largest sellers by role: President and COO Sanjay Gajendra $319M (about $263M of it in May 2026), CEO Jitendra Mohan $234M and Chair Manuel Alba $183M.
- Under Rule 10b5-1 trading plans: about $621M (79%); about $162M (21%) was sold to cover taxes on vesting RSUs.
Insider transactions in detail
- Method: a line-by-line tally of the 64 Forms 4 filed Oct 1, 2025 to Oct 7, 2026, 513 sale lines (SEC EDGAR); classification follows each Form 4’s footnotes. Three more were filed on Oct 9, 2026, including a sale of 12,499 shares (about $4.7M) by Dyckerhoff, not in the tally. None after that through Nov 4.
- About $2.4M was neither plan sales nor tax sales: General Counsel Philip Mazzara, May 18–21, 2026.
- Other sellers: director Stefan Dyckerhoff $29M, others about $21M. Each founder still held about 7.6–8.1M shares after the Aug 17, 2026 filings.
- Mohan, Gajendra, Dyckerhoff and director Jack Lazar adopted trading plans on Dec 1–2, 2025, covering 900,000, 960,000, 150,000 and 20,000 shares (10-K 2025, Item 9B).
- Alba adopted a plan for 1,412,000 shares on May 22, 2026, running to Aug 31, 2027 (10-Q Q2 2026, Item 5). In Q3 2026, Chief Accounting Officer Germaine Cota (13,114 shares, to Nov 19, 2027) and directors Jack Lazar (25,000, to Aug 31, 2027) and Bethany Mayer (1,063, to Nov 30, 2027) adopted plans (10-Q Q3 2026, Item 5). No other director or officer adopted or ended a plan in Q1 or Q2 2026 (10-Q Q1 2026 and 10-Q Q2 2026, Item 5).
5. Profit vs cash (latest FY and TTM)
Last updated Nov 4, 2026. Reflects the 10-K 2025, the Q4 2025 release, the Q3 2026 release and the 10-Q Q3 2026. TTM = the four quarters to Sep 30, 2026 (our calculation)12.
Operating cash flow exceeded GAAP net income in 2025 ($319.3M against $219.1M) but was below it over the last 12 months ($436.7M against $461.3M). Stock-based pay is a non-cash expense that is added back, while fast-rising receivables and inventory absorbed cash. GAAP profit in 2026 was also lifted by tax benefits from employee stock vesting.
| $M | 2025 (disclosed unless marked otherwise) | TTM (our calculation) |
|---|---|---|
| Net income | 219.1 | 461.3 |
| Non-GAAP operating income (company’s reconciliation)13 | 334.4 | 636.1 |
| Non-GAAP net income (company’s reconciliation)13; the TTM also removes a gain on a private equity stake | 331.0 | 604.4 |
| Operating cash flow | 319.3 | 436.7 |
| Capital spending | 37.5 | 92.1 |
| Free cash flow (our calculation)14 | 281.8 | 344.7 |
Sorted by what each of the biggest items between net income and operating cash flow does next (TTM figures are our calculation)15:
Helps future profit or cash:
- Receivables ($44.3M in 2025; $241.5M TTM; $284.3M at Sep 30, 2026, against $83.2M at Dec 31, 2025): sales booked but not yet collected, so the cash arrives when customers pay. Customer A held 58% and Customer B 13% (10-Q).
- Inventory ($13.0M in 2025; $152.0M TTM; $59.0M at Dec 31, 2025 to $200.9M at Sep 30, 2026): cash already spent, with the cost reaching profit when the goods are sold. The 10-Q also cites inventory-related charges in cost of revenue, with no amount.
- Prepaid expenses and other assets ($33.8M in 2025; $28.8M TTM), including a $51.7M income-tax receivable at Sep 30, 2026 (up from $7.5M at Dec 31, 2025): cash paid or owed back to the company.
Hurts future profit or cash:
- Stock pay ($160.0M in 2025; $236.9M TTM): a recurring cost that lowers reported profit; it is added back as a non-cash expense and shows up as new shares (dilution) instead (section 4).
- Amazon’s warrants are booked as a reduction of revenue, not as an expense ($5.5M in 2025 and $30.4M in the first nine months of 2026, $18.1M of it in Q3): they lower reported revenue as Amazon’s purchases occur, with no cash leaving.
One-off / no lasting effect:
- A $50.3M income-tax benefit in Q2 2026, which the 10-Q attributes “primarily” to excess tax benefits from equity compensation. Astera still carries a full valuation allowance against its US deferred tax assets, and the 10-Q says releasing it could cause “a material decrease to income tax expense” in the period it happens (10-Q).
The raw reconciling items
- Stock pay added back $160.0M in 2025 ($236.9M TTM). It is a cost to shareholders through dilution (section 4), not through cash.
- Rising receivables took away $44.3M in 2025 and $241.5M TTM. Receivables were $284.3M at Sep 30, 2026, with Customer A at 58% and Customer B at 13% (10-Q).
- Rising inventory took away $13.0M in 2025 and $152.0M TTM; inventory went from $59.0M at Dec 31, 2025 to $200.9M at Sep 30, 2026.
- Prepaid expenses and other assets took away $33.8M in 2025 and $28.8M TTM. They include a $51.7M income-tax receivable at Sep 30, 2026 (up from $7.5M at Dec 31, 2025).
- GAAP net income also benefits from taxes: the company recorded a $50.3M income-tax benefit in Q2 2026, which the 10-Q attributes “primarily” to excess tax benefits from equity compensation. Astera still carries a full valuation allowance against its US deferred tax assets, and the 10-Q says releasing it could cause “a material decrease to income tax expense” in the period it happens (10-Q).
- Separately, Amazon’s warrants are booked as a reduction of revenue, not as an expense: $5.5M in 2025 and $30.4M in the first nine months of 2026.
Funding: how long without new money? (as of Sep 30, 2026)
Funding details
- Cash, cash equivalents and marketable securities: about $1.38B (our calculation)16 (10-Q). The securities carried $13.3M of gross unrealised losses at Sep 30, mostly corporate debt.
- Debt and convertible notes due within 24 months: none (no debt outstanding; a legacy bank loan expired in January 2022).
- Based on past cash flow; spending plans can change it.
Financing items and other calls on cash, sorted by what they do to the runway:
Extends the runway:
- Undrawn credit lines: none disclosed.
- Money received after Sep 30, 2026: none disclosed.
Shortens the runway:
- $163.6M of minimum purchase commitments through 2030, $7.3M of it in the rest of 2026 (10-Q, note 8).
Conditional:
- At-the-market share-sale programme: none disclosed.
6. Customer and contract exposure
Last updated Nov 4, 2026. Reflects the 10-K 2025 and the 10-Q Q3 2026.
Revenue depends on very few end customers, and the company sells through their contract manufacturers on purchase orders with no minimum volumes.
In short: one unnamed end customer was more than 70% of 2025 revenue, and the top three about 86%. The largest direct customer was 53% of Q3 2026 revenue, but direct customers include contract manufacturers, so their shares can shift without end demand changing.
Show the data
| Label | Customer 1 | Customer 2 | Customer 3 | Customer 4 | Customer 5 | Unit |
|---|---|---|---|---|---|---|
| 2025 | 20 | 20 | 17 | 16 | 11 | % of revenue |
| Q2 2026 | 29 | 25 | 15 | 13 | 0 | % of revenue |
| Q3 2026 | 53 | 14 | 10 | 0 | 0 | % of revenue |
Chart source17. The filings do not say whether customers are the same companies across periods (five direct customers were at 10% or more in 2025, four in Q2 2026, three in Q3 2026).
Customers, supply and contract detail
- In 2025 one end customer (not named) accounted for more than 70% of revenue, and the top three end customers about 86%. Astera estimates this from the end-customer information in its direct customers’ purchase orders. Disclosed.
- Direct customers at 10% or more of revenue: five in 2025 (20%, 20%, 17%, 16%, 11%), four in Q2 2026 (29%, 25%, 15%, 13%) and three in Q3 2026 (53%, 14%, 10%). The 10-Q says certain of them are manufacturing partners that buy on behalf of end customers, so the shares may fluctuate “in a manner that is not necessarily representative of changes in underlying end-customer demand”. Disclosed.
- By billing address, Singapore was 53% of Q3 2026 revenue (29% in Q2), China 25% (39%) and Taiwan 15% (27%) (our calculation)18. These are where direct customers are billed, not where the products are used. Disclosed.
- Sales run on purchase orders. Master agreements with end customers “generally do not require them to purchase a minimum quantity”, and the company reported no unfilled orders under contracts longer than one year at Dec 31, 2025, so it has no reported backlog. Disclosed.
- Named rivals, per the 10-K: Broadcom, Credo, Marvell, Microchip, Montage, Parade and Rambus. Arista isn’t named, but it backs a rival way of linking accelerators (ESUN) to the UALink and PCI Express routes Astera sells into; see the Q3 review.
- Amazon is a customer, according to the Feb 2026 8-K. Whether it is the end customer above 70% is not disclosed.
- Supply: a single manufacturing partner for integrated circuits, and a limited number of other partners for modules, boards and substrates. 65% of property and equipment was in Taiwan at Sep 30, 2026. Disclosed.
| Key contract | Signed | Term | Size | Note |
|---|---|---|---|---|
| Amazon warrant (with October 2023 amendment) | Oct 14, 2022; amended Oct 31, 2023 | Exercisable until the seventh anniversary of issue (October 2029) | Up to 2,316,175 shares at $20.34 | Vests with tranches of Amazon’s purchases. 1,165,513 shares were vested at Dec 31, 2025 (10-K 2025, note 10) |
| Amazon 2026 warrant | Feb 5, 2026 | Exercisable until Feb 5, 2033 | Up to 3,262,299 shares at $142.82 | Vests with up to $6.5B of Amazon purchases of fabric switches, signal-conditioning and optical products. Grant-date fair value of up to $280.0M, booked as reduced revenue as purchases occur; warrants reduced revenue by $18.1M in Q3 2026 (8-K, 10-Q) |
| Headquarters lease, San Jose | Dec 16, 2024; expanded Feb 2026 | 90 months from commencement; expansions run to November 2032 | Initial base rent of $385,578 a month, rising about 3% a year | 8-K, 10-Q Q2 2026, note 7 |
7. What to watch
Last updated Nov 4, 2026. Reflects the 10-K for 2025, the 10-Q for Q3 2026 and the Nov 3, 2026 results and call.
| Date | Item | Source |
|---|---|---|
| Jan 1, 2027 | Annual automatic increase in the 2024 equity plan’s share pool | 10-K 2025 |
| Feb 2027 (expected) | Q4 results against the $730–750M guide, and the 2026 annual report with the year’s end-customer concentration | Q3 2026 release, 10-K 2025 |
| Early 2027 | Whether the lead customer’s current build peaks, as Barclays’ Trip Smith suggested on the Q3 call; the CFO declined to discuss customer volumes but cited continuing deployments | Q3 call |
| Second half of 2027 | Revenue from additional Scorpio X customers, on management’s timing | Q3 call |
| Late 2027 | First revenue from optical products and initial custom silicon shipments, on management’s timing | Q3 call |
| 2027–2028 | Arista’s Ethernet scale-up: trials in 2027, production in 2028, on its CEO’s timing | Arista Q3 call |
| Aug 31, 2027 | End of Chair Manuel Alba’s trading plan for up to 1,412,000 shares | 10-Q Q2 2026 |
| Oct 2029 | The 2022–23 Amazon warrants (2.32M shares at $20.34) reach the end of their exercise period | 10-K 2025 |
Valuation at each update
| Update | Close | Market value | EV | P/S | EV/sales | P/E | P/FCF | Revenue growth | FCF margin | Net cash (debt) | Basis |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2026 | $257.16 (Oct 23) | $43.8B | $42.5B | 36.4× | 35.4× | 118.5× | 158.2× | +99% | 23% | $1.3B | 12 months to Jun 30, 2026 |
| Nov 4, 2026 | $223.27 (Nov 4) | $39.0B | $37.6B | 25.1× | 24.2× | 84.6× | 113.2× | +115% | 22% | $1.4B | 12 months to Sep 30, 2026 |
Our calculation from each update's filings (latest at the newest update: 10-Q for the quarter to Sep 30, 2026, filed Nov 4, 2026); not investment advice. n/m = not meaningful (e.g. negative earnings). Hover a heading for its definition. Oct 28, 2026 price: the Long View's stated close (Stock Analysis). Nov 4, 2026 price: Nasdaq official close (quote page), checked against Yahoo Finance.
Notes and calculations
-
Share of total = each location’s revenue ÷ total 2025 revenue of $852.5M (10-K 2025). ↩
-
Q4 2024 net income = 2024 net loss − nine-month net loss = −$83.421M − (−$108.134M) = $24.713M (10-K 2024; 10-Q for Q3 2024). ↩
-
Beat = $584.9M actual ÷ $560M top of the Q3 guide − 1 = 4.4%. Q4 growth = $740M (midpoint of $730–750M) ÷ $584.9M − 1 = 26.5%. ↩
-
Implied Q3 non-GAAP operating margin = ($550M revenue × 72% non-GAAP gross margin − $158M non-GAAP operating expenses, midpoints) ÷ $550M = 43.3%. ↩
-
Total change = 170.186M ÷ 122.175M − 1 = 39.3%. Annual rate = (170.186 ÷ 122.175)^(1/4) − 1 = 8.6%. ↩
-
1% × 122.175M ÷ 170.186M = 0.72%. ↩
-
0.318M repurchased ÷ 48.329M issued = 0.7%, where 48.329M = shares sold for cash (27.134M) + options exercised (10.801M) + RSUs vested net of withholding (10.116M) + employee purchase plan (0.242M) + acquisition (0.036M). ↩
-
Average price paid = $ spent ÷ shares repurchased, from the equity statements: 2022 $303K ÷ 71K = $4.27; 2023 $174K ÷ 207K = $0.84; 2024 $1,066K ÷ 40K = $26.65. ↩ ↩2 ↩3
-
Gross proceeds = shares sold × price: Series D 7.375M × $20.339 ≈ $150.0M; IPO 19,758,903 × $36.00 = $711.3M. ↩ ↩2
-
Stock pay ÷ revenue (revenue: $79.9M in 2022, $115.8M in 2023, $396.3M in 2024, $852.5M in 2025, $1,285.7M in 9M 2026). ↩
-
Sum of the value of each reported sale line (shares × price) across the 64 Forms 4; plan sales and tax sales are classified from each filing’s footnotes. ↩
-
TTM = 2025 + 9M 2026 − 9M 2025. Net income: $219.134M + $416.342M − $174.152M = $461.324M. Non-GAAP operating income: $334.406M + $526.845M − $225.124M = $636.127M. Non-GAAP net income: $331.015M + $499.284M − $225.876M = $604.423M. Operating cash flow: $319.306M + $341.477M − $224.041M = $436.742M. Capital spending: $37.544M + $73.363M − $18.855M = $92.052M. ↩
-
Company reconciliations: non-GAAP operating income = GAAP operating income + stock pay + acquisition costs; non-GAAP net income = net income + stock pay + acquisition costs − tax effects. ↩ ↩2
-
Free cash flow = operating cash flow − capital spending: 2025 $319.306M − $37.544M = $281.762M; TTM $436.742M − $92.052M = $344.690M. Free cash flow is positive, so the page shows “Self-funding” instead of a runway. ↩ ↩2
-
TTM = 2025 + 9M 2026 − 9M 2025, from the cash-flow statements. Stock pay: $160.033M + $195.495M − $118.659M = $236.869M. Receivables increase: $44.343M + $201.245M − $4.089M = $241.499M. Inventory increase: $12.950M + $146.173M − $7.106M = $152.017M. Prepaid expenses and other assets: $33.757M + $51.767M − $56.760M = $28.764M. ↩
-
Cash and cash equivalents $209.4M + marketable securities $1,168.8M = $1,378.2M at Sep 30, 2026. ↩ ↩2
-
Chart source: 10-K 2025, 10-Q Q2 2026 and 10-Q Q3 2026. ↩
-
Q3 2026 revenue by billing address ÷ $584.9M total: Singapore $310.2M (53%), China $146.7M (25%), Taiwan $87.0M (15%). Q2 figures ÷ $392.4M: Singapore $113.7M (29%), China $152.7M (39%), Taiwan $105.8M (27%). ↩
Quoting this? You may quote short excerpts under our reuse policy. Please credit WhyMyStockMoved.com and link to this page.
About Astera Labs: Website (external site)Investor relations (external site)SEC filings (external site)Wikipedia (external site)